ClostraBio Sales Battle Card: Board Hire & Safety Data
Scott Ravech joins ClostraBio board. CLB101™ safety data published. Pitch compliance and speed to market.
Published on
Do not index
Do not index
🚀 Battle Card: ClostraBio, Inc.
Quick trigger:
👤 Decision Maker in the News
- Scott Ravech, Board of Directors · 🔗 LinkedIn
💡 Why It Matters
- Brings seasoned probiotic leadership and validated safety data, accelerating go-to-market confidence. Use this ClostraBio, Inc. sales trigger to lead with credibility. → Source
🎯 Core Pain Point
- Regulatory & safety validation hurdles for novel microbiome platforms
- Speed to market with practitioner-focused supplement launches
💰 What to Pitch
- Primary: Safety & Compliance Solutions → Mitigate risk, fast-track GRAS validation
- Expansion: GTM Enablement Tools → Streamline practitioner channel rollout
🗺️ Quick Context
- HQ: Chicago, IL
- Employees: ≈ 60
- Rev: ≈ $3 M
- Website: clostrabio.com
🤼 Competitive Intel
*Which other vendors you’ll probably face to win **ClostraBio, Inc.*’s business.
Sales Solutions
- Salesforce — CRM / Sales Automation
- Unique edge: End-to-end pipeline visibility
- Evaluated by VP Sales for scalability
- HubSpot — CRM / Inbound Marketing
- Unique edge: Integrated marketing & sales hub
- Evaluated by Dir. Marketing for ease of use
- Outreach — Sales Engagement
- Unique edge: AI-driven sequencing automation
- Evaluated by Sales Ops for productivity
Marketing Solutions
- Marketo — Marketing Automation
- Unique edge: Deep lead management workflows
- Evaluated by CMO for lead nurturing
- Pardot — B2B Marketing Automation
- Unique edge: Native Salesforce integration
- Evaluated by Dir. Demand Gen for ABM
- Mailchimp — Email Marketing
- Unique edge: User-friendly campaign builder
- Evaluated by Marketing teams for quick deployment
Ops & Supply Chain Solutions
- SAP — ERP / SCM
- Unique edge: Enterprise-grade global support
- Evaluated by COO & VP Ops for end-to-end traceability
- Oracle — ERP / SCM
- Unique edge: Unified finance & supply chain suite
- Evaluated by CFO for cost optimization
- Kinaxis — Supply Chain Planning
- Unique edge: Real-time scenario simulation
- Evaluated by Supply Chain Directors for agility
✅ Do-Now Checklist
Connect with Scott Ravech on LinkedIn (link above)
Email sequence referencing this ClostraBio, Inc. sales trigger & compliance pitch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get daily triggers like this ClostraBio, Inc. sales trigger—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑❑
PROOF_METRIC = ❑❑
CTA_STYLE = ❑❑
TONE = ❑❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Scott
COMPANY = ClostraBio, Inc.
DEPT = Board of Directors
SIZE = ≈ TBD
BOTTLENECK = Regulatory & safety validation hurdles
EVENT = ≈ TBD
DETAIL = ≈ TBD
PAIN = ≈ TBD
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250916252766&div=41152219
SIM_CO = Deerland Probiotics & Enzymes
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 60
REV_EST = ≈ $3 M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ TBD-person Board of Directors
Scott—noticed your Board of Directors team is ≈ TBD.
That’s when Regulatory & safety validation hurdles slows growth.
We helped Deerland Probiotics & Enzymes fix this with ≈ TBD.
Result: ≈ TBD.
Want the 2-min recap?
PS—next bottleneck hits ≈ ≈ TBD.
DM ≤45 words, TONE:
Saw your post about ≈ TBD — ≈ TBD.
≈ TBD. ≈ TBD.
Send case study?